Swiss Initiative To Monitor Missing Medical Devices To Manage Current Product Crisis
Executive Summary
The ongoing availability of many medical devices in Switzerland is threatened even more severely than in the EU. Medtech Insight spoke to two key life science experts to understand why this is and to hear the solutions they are proposing.
You may also be interested in...
Crunch Time: Will EU Allow Article 97 Solution To MDR Bottlenecks Or Will MDR Be Delayed?
Do all roads lead back to the reopening of the Medical Device Regulation and risk-based staggered delays as was introduced with the IVD Regulation? Medtech Insight spoke to TÜV SÜD’s Dr Royth von Hahn and BSI’s Graeme Tunbridge, about how potential solutions to MDR delays are being received.
Getting Back On The EU Agenda Is Uppermost For Swiss Medtech Industry
The Swiss medtech market is now served by 1,200 companies fewer than when its MRA with the EU was still in force. A renewal of the agreement is not a lost hope for the local industry, but at present it is a distant prospect.
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.